Skip to main content

Skin Inflammation

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
AvocadoN/A1 trial
Active Trials
NCT05102604Completed40Est. Dec 2020
Leo Pharma
Leo PharmaDenmark - Ballerup
1 program
Leukotriene B4N/A1 trial
Active Trials
NCT03192280Completed12Est. Jul 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsAvocado
Leo PharmaLeukotriene B4

Clinical Trials (2)

Total enrollment: 52 patients across 2 trials

The Effect of Avocado vs. Usual Diet on Skin Aging

Start: Jan 2020Est. completion: Dec 202040 patients
N/ACompleted
NCT03192280Leo PharmaLeukotriene B4

Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response

Start: Jun 2017Est. completion: Jul 201712 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.